With the aim to study the role of PRRs in the context of cancer, we recently demonstrated that a specific PRR, namely FPR1, functions as a tumor suppressor in gastric cancer (GC) by activating pro-resolving pathways and suppressing angiogenesis [17,21]. Here, FPR1 is linked to neoplasm.